Literature DB >> 7040143

The effect of continuous subcutaneous insulin infusion and conventional insulin regimes on 24-hour variations of blood glucose and intermediary metabolites in the third trimester of diabetic pregnancy.

J M Potter, J P Reckless, D R Cullen.   

Abstract

Twenty-four hour metabolic profiles were performed in the third trimester of pregnancy in seven diabetic women; first when optimally controlled using conventional insulin regimes and subsequently when controlled with continuous subcutaneous insulin infusion. Seven non-diabetic women also studied. Mean +/- SD 24 h metabolite levels in the diabetics before and during continuous subcutaneous insulin infusion and in the controls were respectively: glucose-5.8 +/- 1.2;5.0 +/- 0.9;4.7 +/- 0.8 mmol/l; total ketone bodies -0.2 +/- 0.06; 0.15 +/- 0.05; 0.11 +/- 0.04 mmol/l; lactate - 0.90 +/- 0.33;0.90 +/- 0.24; 1.05 +/- 0.18 mmol/L; alanine - 0.29 +/- 0.06; 0.30 +/- 0.06; 0.31 +/- 0.03 mmol/l. Total ketone body levels were significantly elevated (p less than 0.05) on conventional therapy but not on continuous subcutaneous insulin infusion compared with controls. Variations in metabolites over 24 h, as measured by mean standard deviations, were increased for glucose (p less than 0.001) and for total ketone bodies (p less than 0.05) on the conventional regimes we employed compared with controls. On continuous subcutaneous insulin infusion variations of blood glucose were not affected whereas variations in total ketone bodies were no different from controls. The best possible maternal metabolic control is necessary for normal foetal development and continuous subcutaneous insulin infusion provides a method of achieving this.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7040143     DOI: 10.1007/bf00281544

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Metabolic rhythms in normal and diabetic man. Studies in insulin-treated diabetes.

Authors:  K G Alberti; A Dornhorst; A S Rowe
Journal:  Isr J Med Sci       Date:  1975-06

2.  The infant of diabetic mother.

Authors:  S S GELLIS; D Y Y HSIA
Journal:  AMA J Dis Child       Date:  1959-01

3.  A kinetic spectrophotometric assay for rapid determination of acetoacetate in blood.

Authors:  C P Price; B Llyod; G M Alberti
Journal:  Clin Chem       Date:  1977-10       Impact factor: 8.327

4.  The outcome of diabetic pregnancies in relation to the mother's blood sugar level.

Authors:  K Karlsson; I Kjellmer
Journal:  Am J Obstet Gynecol       Date:  1972-01-15       Impact factor: 8.661

5.  Long-term continuous subcutaneous insulin infusion in diabetics at home.

Authors:  J C Pickup; M C White; H Keen; J A Parsons; K G Alberti
Journal:  Lancet       Date:  1979-10-27       Impact factor: 79.321

6.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.

Authors:  W V Tamborlane; R S Sherwin; M Genel; P Felig
Journal:  N Engl J Med       Date:  1979-03-15       Impact factor: 91.245

7.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Br Med J       Date:  1978-01-28

8.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.

Authors:  R A Rizza; J E Gerich; M W Haymond; R E Westland; L D Hall; A H Clemens; F J Service
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

9.  Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti; A S Rowe
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

10.  Foetal mortality in pregnant diabetics; strict control of diabetes with conservative obstetric management.

Authors:  J PEDERSEN; E BRANDSTRUP
Journal:  Lancet       Date:  1956-05-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.